Mad Money with Jim Cramer – Jan 13, 2026 (Tue): Key Points & Links｜要点・関連リンク

[Jun Kurema (暮眞★潤)]

This page lists the main topics and stocks discussed on Mad Money with Jim Cramer aired on January 13 2026, with links to CNBC articles, videos, and English transcripts.

2026年1月13日放送の 「Mad Money with Jim Cramer」 で取り上げられた主な話題・銘柄を、CNBCの記事・動画・英文トランスクリプトへのリンクとともに一覧化しています。

 

(1) JPMorgan stock will bounce back, Jim Cramer says (https://www.cnbc.com/2026/01/13/jpmorgan-stock-will-bounce-back-jim-cramer-says.html)

• CNBC’s Jim Cramer reviewed Tuesday’s market action and suggested that JPMorgan can recover after its quarterly report sent shares plummeting.
  “Jamie was back urging caution and getting tough about the right to charge high fees for credit cards to make up for losses. That combination created a tsunami of selling,” Cramer said.

Ticker: JPM

 

(2) [No Video Clip for non-Club members] Executive Interview: Novartis CEO Dr. Vasant Narasimhan sits down with Jim Cramer (https://www.cnbc.com/video/2026/01/13/novartis-ceo-dr-vasant-narasimhan-sits-down-with-jim-cramer.html)

Novartis CEO Dr. Vasant Narasimhan joins ‘Mad Money’ host Jim Cramer to talk its product pipeline, vaccine development, utilizing AI, and more.

Ticker: NVS

 

(3) Executive Interview: Amgen CEO says weight loss drug can address ‘patient persistence issue’ (https://www.cnbc.com/2026/01/13/amgen-ceo-weight-loss-drug-can-address-patient-persistence-issue.html)

• Amgen CEO Bob Bradway told CNBC’s Jim Cramer he thinks his company’s obesity drug can help patients maintain weight loss, which he indicated is a challenge.
• “We think we can address one of the reasons that the field is struggling a little bit, which is the patient persistence issue,” Bradway said.

Ticker: AMGN

 

(4) [No Video Clip for non-Club members] Executive Interview: Regeneron CEO: AI is as good as the data it can train on (https://www.cnbc.com/video/2026/01/13/regeneron-ceo-ai-is-as-good-as-the-data-it-can-train-on.html)

Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer joins ‘Mad Money’ host Jim Cramer to talk its product pipeline, utilizing AI in drug development, and more.

Ticker: REGN

 

(5) Cramer’s Lightning Round: Hold Texas Instruments (https://www.cnbc.com/2026/01/13/cramers-lightning-round-hold-texas-instruments.html)

• Texas Instruments: “You want to hold it.”
• Crane: ”…Good company.”
• Catalyst Pharmaceuticals: “I like Catalyst Pharmaceuticals. It actually has, by the way, real earnings, and it’s a very inexpensive stock. I think you’ve got a winner.”

Ticker: TXN,  CR, CPRX

 

(6) [No Video Clip for non-Club members] Executive Interview: Cardinal Health CEO Jason Hollar: We are going to stay focused on the core of our operations and do it better than anyone (https://www.cnbc.com/video/2026/01/13/cardinal-health-ceo-jason-hollar-we-are-going-to-stay-focused-on-the-core-of-our-operations-and-do-it-better-than-anyone.html)

Cardinal Health CEO Jason Hollar joins ‘Mad Money’ host Jim Cramer to talk recent acquisitions, its distribution network, and more.

Ticker: CAH

 

Other Stocks Discussed (calls with audience)/ この日の放送で取り上げられたその他の銘柄（視聴者からの電話): Siri (SIRI) [5% yield; can bounce back; but not my favorite because I like growth and it doesn’t have growth]

 

Ref: Links related to this episode /参考: この日の放送に関するその他のサイトへのリンク:

• Podcast at Spotify (Sound /音声）
• InternetArchive（Video & Texts per minute /1分毎のビデオ＆テキスト）

 

Disclaimer/ 免責事項

****************************

Previous Episode/ 前回のエピソード

Next Episode / 次回のエピソード

 

[Author]

Posts